Difeng Zhu - Publications, H-index & Citations

Difeng Zhu

zhejiang university

17H指数

50论文数

1.0K被引数

收录论文 23

发表时间

Pharmacokinetics and pharmacodynamics studies of different types of insulin with the canine euglycemic clamp 不同类型胰岛素的药代动力学和药效学研究（结合犬类血糖钳夹技术）

Journal of Pharmaceutical Sciences

IF3.8

2026-07-15

PREAI

Difeng Zhu; Chao Chen; Chenxing Yuan

Quantification and Aerodynamic Particle Size Distribution of Revefenacin Aerosol With UHPLC-MS/MS revefenacin气溶胶的定量分析及其空气动力学粒子大小分布（采用UHPLC-MS/MS）

Journal of Separation Science

IF2.8

2025-08-20

PREAI

Difeng Zhu; Jing Dou; Li Ping; Yawen Hong; Chao Chen; Chenxing Yuan; Qixiu Li; Wenjie Luo; Xiaoqing Chi

Vignetting Correction Through Color-Intensity Map Entropy Optimization 基于颜色-强度图熵优化的渐晕校正

ieee transactions on computational social systems

IF4.8

2025-01-01

PREAI

Zhuang He; Hai-Miao Hu; Likun Gao; Haoxin Hu; Xinhui Xue; Zhenglin Tang; Difeng Zhu; Haowen Zheng; Chongze Wang

Comparative Pharmacokinetic Study of Forchlorfenuron in Adult and Juvenile Rats

MOLECULES

IF4.6

2021-07-14

OAAI

Ping, Li; Xu, Bingyong; Zhou, Qian; Hong, Yawen; Sun, Qingmei; Wang, Jincheng; Zhu, Difeng

Effects of prepubertal exposure to forchlorfenuron through prenatal and postnatal gavage administration in developing Sprague-Dawley rats

REPRODUCTIVE TOXICOLOGY

IF2.8

2020-12-01

PREAI

Zhu, Difeng; Ping, Li; Shen, Xiaofei; Hong, Yawen; Weng, Qinjie; He, Qiaojun; Wang, Jiajia; Wang, Jincheng

Simultaneous Quantification and Pharmacokinetic Study of Five Homologs of Dalbavancin in Rat Plasma Using UHPLC-MS/MS 使用uhplc-ms/MS同时定量测定大鼠血浆中达巴万新的五种同系物及其药代动力学研究

MOLECULES

IF4.6

2020-09-08

OAAI

Zhu, Difeng; Ping, Li; Hong, Yawen; Shen, Jiale; Weng, Qinjie; He, Qiaojun

DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase

NATURE COMMUNICATIONS

IF15.7

2020-03-06

150

OAAI

Cao, Ji; Chen, Xiaobing; Jiang, Li; Lu, Bin; Yuan, Meng; Zhu, Difeng; Zhu, Hong; He, Qiaojun; Yang, Bo; Ying, Meidan

Hyperglycemia decreases anti-cancer efficiency of adriamycin via AMPK pathway (vol 27, pg x3, 2020)

ENDOCRINE-RELATED CANCER

IF4.6

2020-02-01

OAAI

Xu, Xiaqing; Si, Meimei; Lou, Honggang; Yan, Youyou; Liu, Yunxi; Zhu, Hong; Lou, Xiaoe; Ma, Jian; Zhu, Difeng; Wu, Honghai; Yanz, Bo; Wu, Haoshu; Ding, Ling; He, Qiaojun

Liquiritin, as a Natural Inhibitor o f AKR1C1, Could Interfere With the Progesterone Metabolism

FRONTIERS IN PHYSIOLOGY

IF3.4

2019-07-03

OAAI

Zeng, Chenming; Zhu, Difeng; You, Jun; Dong, Xiaowu; Yang, Bo; Zhu, Hong; He, Qiaojun

Hyperglycemia decreases anti-cancer efficiency of adriamycin via AMPK pathway

ENDOCRINE-RELATED CANCER

IF4.6

2018-11-01

OAAI

Xu, Xiaqing; Si, Meimei; Lou, Honggang; Yan, Youyou; Liu, Yunxi; Zhu, Hong; Lou, Xiaoe; Ma, Jian; Zhu, Difeng; Wu, Honghai; Yang, Bo; Wu, Haoshu; Ding, Ling; He, Qiaojun

KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells

ACTA PHARMACOLOGICA SINICA

IF8.4

2018-06-21

OAAI

Qi, Xiao-tian; Li, Yang-ling; Zhang, Yan-qi; Xu, Tong; Lu, Bin; Fang, Liang; Gao, Jian-qing; Yu, Lu-shan; Zhu, Di-feng; Yang, Bo; He, Qiao-jun; Ying, Mei-dan

Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-05-31

OAAI

Xian, Miao; Cao, Handi; Cao, Ji; Shao, Xuejing; Zhu, Difeng; Zhang, Ning; Huang, Ping; Li, Weixu; Yang, Bo; Ying, Meidan; He, Qiaojun

Gold nanoparticles coated with polysarcosine brushes to enhance their colloidal stability and circulation time in vivo

JOURNAL OF COLLOID AND INTERFACE SCIENCE

IF9.7

2016-12-01

PREAI

Chen, Ying; Xu, Zhengqing; Zhu, Difeng; Tao, Xinfeng; Gao, Yuqian; Zhu, Hong; Mao, Zhengwei; Ling, Jun

Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation

CELL DEATH & DISEASE

IF9.6

2015-04-09

OAAI

Li, L.; Li, T.; Zhang, Y.; Pan, Z.; Wu, B.; Huang, X.; Zhang, Y.; Mei, Y.; Ge, L.; Shen, G.; Ge, R-s; Zhu, D.; Lou, Y.

The Selectivity and Potency of the New PDE5 Inhibitor TPN729MA

JOURNAL OF SEXUAL MEDICINE

IF3.3

2013-11-01

PREAI

Wang, Zhen; Zhu, Difeng; Yang, Xiaochun; Li, Jianfeng; Jiang, Xiangrui; Tian, Guanghui; Terrett, Nicholas Kenneth; Jin, Jie; Wu, Honghai; He, Qiaojun; Yang, Bo; Shen, Jingshan

Efficacy of all-trans retinoid acid in preventing nickel induced cardiotoxicity in myocardial cells of rats

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2013-01-01

PREAI

Lou, Siyue; Zhong, Like; Yang, Xiaochun; Xue, Tao; Gai, Renhua; Zhu, Difeng; Zhao, Yuqin; Yang, Bo; Ying, Meidan; He, Qiaojun

Inhibition of All-Trans-Retinoic Acid-Induced Proteasome Activation Potentiates the Differentiating Effect of Retinoid in Acute Myeloid Leukemia Cells

MOLECULAR CARCINOGENESIS

IF3.2

2010-10-13

PREAI

Fang, Yanfen; Zhou, Xinglu; Lin, Meihua; Ying, Meidan; Luo, Peihua; Zhu, Difeng; Lou, Jianshu; Yang, Bo; He, Qiaojun

Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells

INVESTIGATIONAL NEW DRUGS

IF2.7

2010-08-05

PREAI

Zhang, Lei; Yan, Yan; Zhu, Difeng; Yang, Wei; Wang, Weisi; Hu, Yongzhou; Yang, Bo; He, Qiaojun

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells 喹喔啉1，4-二氮氧化物衍生物Q39抑制人肝癌细胞中缺氧诱导因子-1α 的表达和Akt/mTOR/4E-BP1信号通路

INVESTIGATIONAL NEW DRUGS

IF2.7

2010-06-05

PREAI

Weng, Qinjie; Zhang, Jun; Cao, Ji; Xia, Qing; Wang, Duoduo; Hu, Yongzhou; Sheng, Rong; Wu, Honghai; Zhu, Difeng; Zhu, Hong; He, Qiaojun; Yang, Bo

5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis

INVESTIGATIONAL NEW DRUGS

IF2.7

2010-03-30

PREAI

Xu, Danqing; Cao, Ji; Qian, Shijing; Li, Lin; Hu, Chunqi; Weng, Qinjie; Lou, Jianshu; Zhu, Difeng; Zhu, Hong; Hu, Yongzhou; He, Qiaojun; Yang, Bo

研究方向